Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a ...

(AP Photo/Darron Cummings, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Eli Lilly’s profit ...

People with diabetes should eat as much protein as people who don't have diabetes. In a healthy diet, roughly 10% to 35% of your daily calories should come from protein. Protein itself does not have ...

However in the US, where its maker Eli Lilly is headquartered ... Alongside Ozempic and Wegov – the anti-diabetes and weight-loss jabs made by Danish company Novo Nordisk – Mounjaro and ...

Patients to pay no more than $35 a month Eli Lilly, Sanofi previously settled ... makers of charging astronomically high prices for the diabetes drug. It requires Novo Nordisk to cap out-of ...

For the past year, Jonsson has run Lilly Diabetes and Obesity, which means he oversees everything from insulin shots to the newer, high-demand drugs now known as "weight-loss" shots: Mounjaro ...

The Diabetes Support Group meets from 11 a.m.-noon, the fourth Monday of the month in the Lilly Lake Conference Room, at Northwest Health — LaPorte, 1331 State St. Registration is not required.

For the past year, Jonsson has run Lilly Diabetes and Obesity, which means he oversees everything from insulin shots to the newer, high-demand drugs now known as "weight-loss" shots: Mounjaro, ...

Now, in a rational world, insurers would immediately switch to the generic drug so patients with diabetes could save money. Instead, pharmacy benefit managers — which determine what drugs ...

Companies including Biogen and Eli Lilly & Co. have spent billions of ... Novo Nordisk is testing whether the ingredient — which is in its diabetes and weight-loss drugs — can benefit patients ...